 | Yahoo! Health - My Alerts - Edit Alert |
| Thursday, Mar 07, 2013 07:11 AM EST | |
| GlaxoSmithKline files for European approval of diabetes drug albiglutide reuters.com Thu, 07 Mar, 2013 04:08 AM PST LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline said on Thursday it had filed for European approval of its new once-weekly diabetes drug albiglutide, as tries to gain a foothold in a crowded market. Albiglutide, used to treat type 2 diabetes, belongs to the same class of injectable GLP-1 medicines as Victoza, from Novo Nordisk, and Byetta and Bydureon, from Bristol-Myers Squibb ... GSK files for European approval of diabetes drug albiglutide reuters-ukfocus.com Thu, 07 Mar, 2013 04:03 AM PST Britain's biggest drugmakerGlaxoSmithKline said on Thursday it had filed forEuropean approval of its new once-weekly diabetes drugalbiglutide, as tries to gain a foothold in a crowded market. Albiglutide, ... UTHSC awarded $333K diabetes research grant Thu, 07 Mar, 2013 03:19 AM PST MEMPHIS, Tenn. (AP) â€" U.S. Rep. Steve Cohen says the University of Tennessee Health Science Center has been awarded a federal grant of more than $333,000 for diabetes, endocrinology and metabolic research. Cohen said in a statement Tuesday that the center, located in Memphis, was awarded the grant by the U.S. Department of Health and Human Services. The $333,102 will be distributed by the ... Diabetes costs nation $245 billion annually Thu, 07 Mar, 2013 02:20 AM PST The growing toll of diabetes cost the nation $245billion in 2012, a 41percent increase from $174billion in 2007, according to new research. Do more women need diabetes care when pregnant? Thu, 07 Mar, 2013 02:09 AM PST A change in testing could nearly triple the number of women diagnosed with diabetes during pregnancy, but would catching milder cases help mother or baby? Diabetes tests in pregnancy under review Thu, 07 Mar, 2013 01:51 AM PST WASHINGTON - A change in testing could nearly triple the number of women diagnosed with diabetes during pregnancy, but would catching milder cases help mother or baby? A government panel is urging more research to find that out before doctors make the switch. Bestellen Sie den kostenlosen Newsletter von 4investors: Thu, 07 Mar, 2013 01:48 AM PST Poxel S.A. / First Patient In for Poxel's Imeglimin Phase IIb Monotherapy Trial to Treat Type 2 Diabetes . Processed and transmitted by Thomson Reuters ONE. PRESS RELEASE: First Patient In for Poxel's Imeglimin Phase IIb Monotherapy Trial to Treat Type 2 Diabetes Thu, 07 Mar, 2013 01:46 AM PST Poxel S.A. / First Patient In for Poxel's Imeglimin Phase IIb Monotherapy Trial to Treat Type 2 Diabetes . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Lyon, ... Book Review: Diabetes ABC by Dr. Sherry L. Meinberg Thu, 07 Mar, 2013 01:35 AM PST Book Review: Diabetes ABC by Dr. Sherry L. Meinberg Seattle Post-Intelligencer Copyright 2013 Seattle Post-Intelligencer. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Published 8:29 pm, Wednesday, March 6, 2013 [...] it does happen and instances of juvenile diabetes unfortunately are on the rise and at an alarming rate. The book discusses ... Post-retirement, some can face health pitfalls Thu, 07 Mar, 2013 01:27 AM PST Designing such studies is difficult because retirees are usually older than workers and the conditions that are typically measured, such as cardiovascular disease, diabetes, cancer and arthritis, become more common as people age. [...] in 1983 researchers assessed the effects of retirement on 638 men ages 55 to 73 as part of a Department of Veterans Affairs effort called the Normative Aging ... | |
|
No comments:
Post a Comment